Dr Markand Patel BM, BSc, FRCR

Institute of Cancer and Genomic Sciences
Clinical Research Fellow

Contact details

Email
m.d.patel@bham.ac.uk
View my research portal
Address
Institute of Cancer and Genomic Sciences
University of Birmingham
Edgbaston
Birmingham
B15 2TT

Dr Markand Patel is a Clinical Research Fellow in Imaging at the University of Birmingham and a Clinical Radiology trainee in the West Midlands, with a specialist interest in Neuroradiology. His research interests are brain tumours, advanced imaging, radiomics, and artificial intelligence.

Qualifications

  • FRCR, Royal College of Radiologists, 2018
  • BM, University of Southampton, 2011
  • BSc (Hons) Radiological Sciences, King’s College London, 2009

Biography

Dr Markand Patel completed his medical training from the University of Southampton in 2011 and obtained a First Class Honours intercalated BSc in Radiological Sciences from King’s College London. 

He undertook Academic Foundation training in Bristol, after which he gained experience of research trials at the NIHR/Wellcome Trust Imperial Clinical Research Facility in London. Markand then commenced Clinical Radiology training in the West Midlands and has won numerous prizes and awards during his undergraduate and postgraduate training. 

In 2017, Markand was awarded a competitive Institute of Translational Medicine research fellowship by Birmingham Health Partners. His PhD, supervised by Professor Vijay Sawlani, is focussed on the early detection of treatment response in brain tumours using imaging and artificial intelligence.

Publications

Sawlani V, Patel M. Three-dimensional double inversion recovery magnetic resonance sequence detects perilesional gliosis better than 3D-FLAIR and postcontrast T1 imaging in calcified neurocysticercosis. Neurol India 2019;67:74-5.

Sawlani V, Davies N, Patel M, Flintham R, Fong C, Heyes G, Cruickshank G, Steven N, Peet A, Hartley A, Benghiat H, Meade S, Sanghera P. Evaluation of Response to Stereotactic Radiosurgery in Brain Metastases Using Multiparametric Magnetic Resonance Imaging and a Review of the Literature. Clin Oncol2019;31(1):41-49.

Blagden SP, Rizzuto I, Suppiah P, O’Shea D, Patel M, Sukumaran A, Bharwani N, Rockall A, Gabra H, El-Bahrawy M, Wasan H, Leonard R, Habib N, Ghazaly E. Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I study. Br J Cancer 2018;119(7):815-822. 

Pinato DJ, Pai M, Reccia I, Patel M, Giakoustidis A, Karamanakos G, Rushd A, Jamshaid S, Oldani A, Grossi G, Pirisi M, Tait P, Sharma R. Preliminary qualification of a novel, hypoxic-based radiologic signature for trans-arterial chemoembolization in hepatocellular carcinoma. BMC Cancer 2018;18(1):211.

Patel MD, Sawlani V. Can arterial spin labelling really replace dynamic susceptibility contrast perfusion techniques for assessing brain tumours in clinical practice? Neurol India 2017;65:977-8. 

Patel MD, Harris M, Tapply I, Longman RJ. Improving adherence to guidelines for extended venous thromboembolism prophylaxis in patients with colorectal cancer  BMJ Quality Improvement Reports 2013;2: doi:10.1136/bmjquality.u200573.w1062.

Patel MD. Toussaint N, Charles-Edwards GD, Lin J-P, Batchelor P. Distribution and fibre field similarity mapping of the human anterior commissure fibres by diffusion tensor imaging. Magnetic Resonance Materials in Physics, Biology and Medicine 2010;23(5):399-408.

View all publications in research portal